Ask AI
ProCE Banner Series

Updates for Community Practice-Optimizing Testing, First-line Treatment, and Supportive Care for Patients With BRAF V600E–Mutant mCRC and mNSCLC

Join us for this interactive, live CME/CE-certified webinar featuring expert perspectives on the use of targeted therapy for advanced BRAF V600E–mutant CRC and NSCLC, with a focus on recent practice-changing studies. Be sure to bring your questions for the live Q&A session with the expert panel. 

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for oncologists, oncology nurses and nurse practitioners, physician associates, pharmacists, and other healthcare professionals involved in the care and treatment of patients with mCRC and/or mNSCLC in community practices.

All Events

Updates for Community Practice-Optimizing Testing, First-line Treatment, and Supportive Care for Patients With BRAF V600E–Mutant mCRC and mNSCLC 

Upcoming Events

February

13

2026

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Lung cancers, gastrointestinal cancers, colorectal cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, competence, and confidence in the evidence-based management of patients with BRAF V600E-mutant mCRC and NSCLC by facilitating the application of updated guideline-recommended strategies, optimizing biomarker testing workflows, and integrating patient- and disease-specific considerations into individualized treatment planning.

Target Audience
This activity is intended for oncologists, oncology nurses and nurse practitioners, physician associates, pharmacists, and other healthcare professionals involved in the care and treatment of patients with mCRC and/or mNSCLC in community practices.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply the latest evidence and guideline recommendations for the first-line treatment of patients with BRAF V600E-mutant mCRC and mNSCLC

  • Integrate biomarker testing workflows to improve identification and timely treatment selection for patients with BRAF V600E-mutant mCRC and mNSCLC

  • Implement practical strategies to manage adverse events associated with BRAF-targeted combination therapies through appropriate dose modifications and supportive care

  • Collaborate across multidisciplinary care teams to personalize treatment plans and ensure optimal outcomes for patients with BRAF-mutant mCRC and mNSCLC

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191